CD9 and neoplasm: The literature reports also demonstrate that TBX3 upregulates important gene targets involved in tumor development, angiogenesis and ion transport such as versican (VCAN), CD9, chromo-domain helicase DNA binding protein 1 (CHDR1) and CD86.